Simplex Trading’s Endovia Health Sciences, Inc. EDVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-71
Closed -$1K 9526
2024
Q4
$1K Sell
71
-1
-1% -$33 ﹤0.01% 8308
2024
Q3
$2K Buy
72
+11
+18% +$554 ﹤0.01% 8061
2024
Q2
$2K Sell
61
-12
-16% -$563 ﹤0.01% 8341
2024
Q1
$5K Sell
73
-45
-38% -$3.58K ﹤0.01% 8037
2023
Q4
$10K Sell
118
-4
-3% -$381 ﹤0.01% 7450
2023
Q3
$11K Sell
122
-23
-16% -$2.98K ﹤0.01% 7129
2023
Q2
$25K Buy
145
+55
+61% +$10.1K ﹤0.01% 6552
2023
Q1
$23K Buy
90
+76
+543% +$15.1K ﹤0.01% 6792
2022
Q4
$2K Sell
14
-73
-84% -$12.8K ﹤0.01% 8640
2022
Q3
$18K Sell
87
-31
-26% -$11.8K ﹤0.01% 7639
2022
Q2
$56K Buy
+118
New +$42.6K ﹤0.01% 6344

Other funds holding EDVA

Simplex Trading's EDVA Position: Q1 2025 in Review

Simplex Trading sold out of Endovia Health Sciences, Inc. (EDVA) in Q1 2025, closing a stake of 71 shares — an estimated $1K sold.

Simplex Trading first reported a position in EDVA in Q2 2022 and held it in 11 quarters. The position peaked at $56K in Q2 2022. 11 funds tracked by Wall St. Rank hold EDVA as of Q1 2025.

  • Simplex Trading reported no remaining Endovia Health Sciences, Inc. position as of Q1 2025 after selling out during the quarter.
  • Simplex Trading sold 71 Endovia Health Sciences, Inc. shares in Q1 2025, an estimated $1K.
  • Simplex Trading first reported a position in Endovia Health Sciences, Inc. in Q2 2022 and held it in 11 quarters.
  • Simplex Trading's Endovia Health Sciences, Inc. position peaked at $56K in Q2 2022.
  • 11 funds tracked by Wall St. Rank held Endovia Health Sciences, Inc. as of Q1 2025.

Based on Simplex Trading's 13F filing for Q1 2025, filed 12 May 2025.